Validation of a Parental Questionnaire for Screening Children for Neurovisual Disorders
1 other identifier
observational
250
1 country
1
Brief Summary
Some children present visual difficulties linked not to damage to the eye, but to damage to the brain. This type of dysfunction of the visual cerebral pathways leads, for example, to difficulties in recognition, visuomotor coordination or visuo-spatial disorders. These highly specific disorders are known as "cortical visual impairment" (CVI). Despite their real impact on children's development, these disorders are still poorly diagnosed in the French-speaking world. As a result, follow-up and care for these children are poorly adapted. A better understanding of neurovisual disorders and the availability of validated tools in French are therefore essential. Indeed, it is currently considered that 3 to 4% of children aged four to six, i.e. around one child per kindergarten class, have a CVI following a neuro-logical lesion acquired in the perinatal period. Because of the lack of a valid tool in French, the aim of the present study is to provide the results of a validation study of a parental questionnaire for screening children with warning signs of CVI in French. This questionnaire will be offered online using the Qualtrics tool. In order to evaluate the relevance of this questionnaire, it will be proposed, on the one hand, to parents whose child (aged 3 to 12) does not present any particular developmental difficulties, and on the other hand, to parents whose child (aged 3 to 12) seems to present signs of neurovisual disorders. By comparing their answers, the investigators hope that certain questions will reveal elements typical of neurovisual disorders/CVI, thus demonstrating the relevance of this questionnaire in facilitating diagnosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2025
CompletedFirst Submitted
Initial submission to the registry
May 12, 2025
CompletedFirst Posted
Study publicly available on registry
May 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2026
ExpectedMay 30, 2025
May 1, 2025
3 months
May 12, 2025
May 21, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
typical behaviors of CVI
The scores obtained represent a difficulty, an absence of mastery of a skill. Thus, a high score means that the child has some visual difficulties, while a low score means that the child has no difficulties.
Through study completion, an average of 14 months
Study Arms (1)
questionnaire
Each parent has to complete a online questionnaire
Interventions
Eligibility Criteria
In order to evaluate the relevance of this questionnaire, it will be proposed to parents whose children (aged 3 to 12) do not present any particular developmental difficulties, and to parents whose children (aged 3 to 12) appear to present signs of neurovisual disorders.
You may qualify if:
- Parents of a child aged between 3 and 12
- Their mother tongue must be French, to ensure that they understand the questions asked in writing.
- Control group:
- \- Children of the parents surveyed who do not present any medical, school or family developmental particularities.
- Clinical group
- \- Children of the parents interviewed who present warning signs of CVI reported by a multidisciplinary team specialized in visual impairment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
10 place cardinal Mercier
Louvain-la-Neuve, 1348, Belgium
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 12, 2025
First Posted
May 30, 2025
Study Start
April 1, 2025
Primary Completion
June 15, 2025
Study Completion (Estimated)
June 15, 2026
Last Updated
May 30, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share